Michael Samar

Michael Samar

Direttore/Membro del Consiglio presso
Outbio Bay Area, Inc.
53 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Michael P.
Samar
currently works at Outbio Bay Area, Inc., as Treasurer & Director.
Mr. Samar also formerly worked at Onyx Pharmaceuticals, Inc., as Director-Financial Planning & Analysis in 2013, Agennix, Inc., as Senior Finance Director-Global Planning & Analysis from 2005 to 2013, Unity Biotechnology, Inc., as Independent Director from 2022 to 2025, Acorda Therapeutics, Inc., as Vice President-Finance from 2014 to 2017, Johnson & Johnson Pharmaceutical Research & Development LLC, as Principal from 1999 to 2005, Windgap Medical, Inc., as Chief Financial Officer from 2023 to 2024, Assembly Biosciences, Inc., as Chief Financial & Accounting Officer from 2021 to 2022, and Assembly Biosciences, Inc., as Chief Financial Officer.
Mr. Samar received his Masters Business Admin degree from Villanova University and undergraduate degree from Bryant University.

Posizioni attive di Michael Samar

SocietàPosizioneInizio
Outbio Bay Area, Inc.
Direttore/Membro del Consiglio -

Precedenti posizioni note di Michael Samar

SocietàPosizioneFine
UNITY BIOTECHNOLOGY, INC. Direttore/Membro del Consiglio 27/06/2025
Direttore Finanziario/CFO 01/12/2024
ASSEMBLY BIOSCIENCES, INC. Direttore Finanziario/CFO 12/08/2022
ACORDA THERAPEUTICS, INC. Direttore Finanziario/CFO 01/04/2017
Corporate Officer/Principal 01/12/2013
Vedi nel dettaglio l'esperienza di Michael Samar

Formazione di Michael Samar

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

63

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Outbio Bay Area, Inc.

  1. Mercati
  2. Insiders
  3. Michael Samar
40% di sconto: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA